Ignite Creation Date:
2025-12-24 @ 7:04 PM
Ignite Modification Date:
2025-12-25 @ 4:38 PM
Study NCT ID:
NCT06146257
Status:
RECRUITING
Last Update Posted:
2025-10-21
First Post:
2023-11-10
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
Sponsor:
GluBio Therapeutics Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-11
Start Date Type:
ACTUAL
Primary Completion Date:
2026-07-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-10-08
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-10
First Submit QC Date:
None
Study First Post Date:
2023-11-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-17
Last Update Post Date:
2025-10-21
Last Update Post Date Type:
ESTIMATED